MSF and the Mini-Lab team were present at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Lisbon, Portugal from 23 to 26 April 2022.
MSF is pleased to announce the partnership between MSF and WHONET to integrate WHONET's expertise into the Laboratory Information Management System (Mini-LIMS) to facilitate the interpretation of antibiotic susceptibility tests (AST)
The MSF Foundation is innovating by adapting a tool to help healthcare workers manage diabetic ketoacidosis, a severe acute complication in children with diabetes.
In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated...
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial